![](https://bloximages.newyork1.vip.townnews.com/wfmz.com/content/tncms/assets/v3/editorial/9/d4/9d43ba92-e948-5aeb-bada-c55d33ddcb89/610bc6523457b.image.jpg?crop=1128%2C592%2C322%2C0&resize=1128%2C592&order=crop%2Cresize)
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
Appointment Completes Executive Readiness for Registrational Phase 3b ALS Study Launch NEW YORK, June 20, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for …